Meeder Asset Management Inc Checkpoint Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.97 - $1.77 $927 - $1,692	-956 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$1.53 - $3.25 $1,462 - $3,107	956 New	956 $2,000
Q4 2021 Feb 11, 2022	SELL	$2.68 - $4.46 $2,452 - $4,080	-915 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$2.6 - $4.16 $2,379 - $3,806	915 New	915 $3,000
Q4 2020 Feb 09, 2021	SELL	$2.19 - $2.96 $2,003 - $2,708	-915 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.11 - $2.43 $1,015 - $2,223	915 New	915 $1,000
Q4 2019 Feb 13, 2020	SELL	$1.18 - $2.39 $818 - $1,658	-694 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$2.15 - $3.36 $1,492 - $2,331	694 New	694 $2,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.